AMPATH-Oncology Institute: HPV and Cervical Cancer in Kenyan Women with HIV/AIDS

AMPATH-肿瘤学研究所:感染艾滋病毒/艾滋病的肯尼亚妇女中的 HPV 和宫颈癌

基本信息

项目摘要

The interaction of human papillomavirus (HPV) with human immunodeficiency virus (HIV) represents one of the most "dangerous liaisons" for women in Sub-Saharan Africa. In high-income countries, the most common of these high-risk HPVs (HR-HPVs) are HPV 16 and 18, which are the targets of two commercially available bivalent and quadrivalent vaccines. However, a wider spectrum of HR-HPV types and a higher incidence of multiple HPV infections have been reported in women from low- to middle-income countries (LMCs). Worldwide, it is estimated that over 500,000 cases of cervical cancer are diagnosed yearly, with 85% of these in LMCs. In Africa, approximately 80,000 women are diagnosed with cervical cancer and 60,000 die from the disease annually, making it the leading cause of cancer death among women. Sub-Saharan Africa also contains 70% of the world's diagnosed cases of HIV, with Kenya as one of Africa's epicenters. Recent studies show that HIV is clearly a contributing factor for cervical carcinogenesis; HIVinfected women have a greater incidence and persistence of HPV infections and suffer from a markedly higher incidence of cervical cancer and cervical intraepithelial neoplasia (CIN). The "perfect storm" of these two families of viruses only begins to explain why both incidence and mortality of cervical cancer in Sub- Saharan Africa are three-fold that of the United States. Other co-morbidity factors, such as sexually transmitted infections (STIs), environmental issues, anti-retroviral and other therapies, and their relation to HR-HPV carcinogenesis, need further study if a major impact is to be made in cervical cancer. The core objective of this application is to better understand the natural history of oncogenic HPV infections in HIV-infected Kenyan women, and the potentially modifiable (and non-modifiable) factors that are associated with progression of oncogenic HPV infection to clinical disease, including cervical cancer. Additionally, with the creation of a multinational, transdisciplinary program entitled the AMPATH-Oncology Institute, a mentoring program will be established to foster development of new cancer researchers in Kenya. Our expected outcome is the establishment of a dedicated core of cancer-focused Kenyan investigators who embody a culture of translational and collaborative research.
人乳头瘤病毒(HPV)与人类免疫缺陷病毒(HIV)的相互作用是人类免疫缺陷病毒(HIV)的一种

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DARRON R BROWN其他文献

DARRON R BROWN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DARRON R BROWN', 18)}}的其他基金

Project 1-Preventing cervical cancer in HIV-infected women
项目1-艾滋病毒感染妇女预防宫颈癌
  • 批准号:
    10477367
  • 财政年份:
    2020
  • 资助金额:
    $ 64.71万
  • 项目类别:
Project 1-Preventing cervical cancer in HIV-infected women
项目1-艾滋病毒感染妇女预防宫颈癌
  • 批准号:
    10256042
  • 财政年份:
    2020
  • 资助金额:
    $ 64.71万
  • 项目类别:
The East Africa Consortium for HPV and Cervical Cancer in Women living with HIV/AIDS
东非艾滋病毒/艾滋病女性 HPV 和宫颈癌联盟
  • 批准号:
    10084048
  • 财政年份:
    2020
  • 资助金额:
    $ 64.71万
  • 项目类别:
The East Africa Consortium for HPV and Cervical Cancer in Women living with HIV/AIDS
东非艾滋病毒/艾滋病女性 HPV 和宫颈癌联盟
  • 批准号:
    10256037
  • 财政年份:
    2020
  • 资助金额:
    $ 64.71万
  • 项目类别:
The East Africa Consortium for HPV and Cervical Cancer in Women living with HIV/AIDS
东非艾滋病毒/艾滋病女性 HPV 和宫颈癌联盟
  • 批准号:
    10477359
  • 财政年份:
    2020
  • 资助金额:
    $ 64.71万
  • 项目类别:
Project 1-Preventing cervical cancer in HIV-infected women
项目1-艾滋病毒感染妇女预防宫颈癌
  • 批准号:
    10084053
  • 财政年份:
    2020
  • 资助金额:
    $ 64.71万
  • 项目类别:
Translational Biology Core
转化生物学核心
  • 批准号:
    8935196
  • 财政年份:
    2014
  • 资助金额:
    $ 64.71万
  • 项目类别:
AMPATH-Oncology Institute: HPV and Cervical Cancer in Kenyan Women with HIV/AIDS
AMPATH-肿瘤学研究所:感染艾滋病毒/艾滋病的肯尼亚妇女中的 HPV 和宫颈癌
  • 批准号:
    8794571
  • 财政年份:
    2014
  • 资助金额:
    $ 64.71万
  • 项目类别:
Project 2
项目2
  • 批准号:
    8935185
  • 财政年份:
    2014
  • 资助金额:
    $ 64.71万
  • 项目类别:
Project 1
项目1
  • 批准号:
    8935184
  • 财政年份:
    2014
  • 资助金额:
    $ 64.71万
  • 项目类别:

相似海外基金

Photodecarboxylation of coumarinyl acetic acids
香豆素乙酸的光脱羧
  • 批准号:
    382526-2009
  • 财政年份:
    2009
  • 资助金额:
    $ 64.71万
  • 项目类别:
    University Undergraduate Student Research Awards
Photodecarboxylation of Coumarinyl Acetic Acids
香豆素乙酸的光脱羧
  • 批准号:
    351783-2007
  • 财政年份:
    2007
  • 资助金额:
    $ 64.71万
  • 项目类别:
    University Undergraduate Student Research Awards
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了